Target intelligence / Profile preview

Harmonin (USH1C) (USH1C)

Target
USH1C
Molecular classification
Scaffold protein, PDZ domain-containing protein, Other
01

Overview

Harmonin, encoded by the USH1C gene, is a multi-PDZ domain scaffold protein essential for the structural integrity and function of sensory hair cells in the inner ear and photoreceptor cells in the retina (UniProt Q9Y6N9). In retinal cells, harmonin is localized to the photoreceptor connecting cilium and synaptic terminals, where it coordinates protein networks involved in intracellular transport and signal transduction (PubMed: 21822275). Deficiency of functional harmonin, typically due to autosomal recessive mutations, results in Usher syndrome type 1C, a condition characterized by profound deafness and progressive blindness from retinitis pigmentosa (NIH: Genetic Home Reference). Therapeutic approaches currently under investigation include gene replacement therapy using adeno-associated virus (AAV) vectors and antisense oligonucleotides (ASOs) designed to correct specific splicing mutations, such as the c.216G>A Acadian mutation (PubMed: 28165461). These interventions aim to restore harmonin expression to prevent or delay retinal degeneration and hearing loss by stabilizing the Usher protein network within the eye.

Other names
PDZ domain-containing protein USH1CUsher syndrome type-1C proteinAIE-75DFNB18NY-CO-38PDZ-73
02

Mechanism of action

Restoration of functional harmonin protein levels through adeno-associated virus (AAV) mediated gene replacement or the use of antisense oligonucleotides (ASOs) to correct pre-mRNA splicing defects, specifically targeting the c.216G>A mutation.

03

Biological functions

Protein-protein interactionOrganization of stereociliaRetinal photoreceptor maintenanceMechanotransductionIntracellular transport coordination
04

Disease associations

Usher syndrome type 1CRetinitis pigmentosaSensorineural hearing lossDeafness, autosomal recessive 18
05

Safety considerations

Immune response to viral vectorsRetinal detachment or damage from subretinal injectionOff-target effects of antisense oligonucleotidesPotential toxicity from harmonin overexpression in non-target cells
06

Interacting drugs

ASO-216 (Antisense oligonucleotide)

1 more in the full profile.

07

Biomarkers

USH1C gene mutation statusElectroretinogram (ERG) amplitudesOptical Coherence Tomography (OCT) outer nuclear layer thicknessVisual field sensitivity

Beyond the preview

Go deeper on Harmonin (USH1C) (USH1C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Harmonin (USH1C) (USH1C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call